Rational engineering of a novel complement regulator-based therapeutic affords triple targeting of host surfaces and pathway-specific inhibition of complement activation
Journal article published in 2012 by
Christoph Q. Schmidt,
Hongjun Bai,
Zhuoer Lin,
Antonio M. Risitano,
Paul N. Barlow,
Daniel Ricklin 
,
John D. Lambris
,
John D. Lambris
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Postprint:
archiving forbidden
Published version:
archiving forbidden
Data provided by 